Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000083
Filing Date
2024-12-09
Accepted
2024-12-09 16:21:23
Documents
5
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 6-K a2024-12x10fdagrantsmesobl.htm 6-K 20849
2 EX-99.1 exhibit991.htm EX-99.1 13046
3 exhibit991001.jpg GRAPHIC 272134
4 exhibit991002.jpg GRAPHIC 310449
5 exhibit991003.jpg GRAPHIC 208903
  Complete submission text file 0001345099-24-000083.txt   1125328
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 241535365
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)